How Much Did BioAssay Works Raise?
Funding & Key Investors

BioAssay Works has successfully secured a major strategic investment, marking a significant milestone in its corporate trajectory. This latest capital infusion, totaling $150K, underscores the firm's robust market position within the diagnostic technology sector. With a cumulative financial backing of $150K, the company is well-positioned to accelerate its operational scale and deepen its influence in the precision testing landscape.

What is BioAssay Works?

BioAssay Works
Business ServicesResearch & DevelopmentManufacturing

BioAssay Works LLC operates as a specialized leader in the development of precision lateral flow assays and advanced gold nanoparticle solutions. By bridging the gap between complex laboratory-grade sensitivity and the accessibility of point-of-care environments, the firm serves a diverse array of industries, including human medicine, veterinary diagnostics, food safety, and environmental monitoring. Their core competency lies in custom assay development and contract manufacturing, leveraging over two decades of technical expertise to drive down development costs while simultaneously enhancing the performance of rapid diagnostic tests. As a critical partner in the global supply chain for diagnostics, the company provides the essential infrastructure required for high-throughput, reliable testing solutions across multiple regulatory and commercial domains.

How much funding has BioAssay Works raised?

BioAssay Works has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in BioAssay Works

PPP

Public-Private Partnership

What's next for BioAssay Works?

The recent influx of capital is expected to catalyze the next phase of growth for BioAssay Works, particularly as the firm looks to expand its contract manufacturing capabilities and refine its proprietary gold conjugation technologies. Given the current late-stage funding context, the organization is likely prioritizing the optimization of its production facilities to meet the surging global demand for rapid, point-of-care diagnostic tools. Strategic initiatives will likely focus on scaling internal R&D to maintain a competitive edge in assay sensitivity, while simultaneously exploring new market verticals that require high-performance, cost-effective testing solutions. By leveraging this financial backing, BioAssay Works is poised to solidify its role as a foundational provider in the evolving landscape of decentralized healthcare and industrial monitoring.

See full BioAssay Works company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject ManagementSoftware Testing
Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)Project Management
Business ServicesProject Management
Business ServicesCommercial Printing

Frequently Asked Questions Regarding BioAssay Works Financial Insights

What are the most recent funding rounds that BioAssay Works has completed, and what were the funding rounds?
BioAssay Works has recently completed 1 funding rounds: Debt on Apr 7, 2020.
What is the total amount of funding BioAssay Works has raised to date?
BioAssay Works has raised a total of $150K in funding to date.
How many funding rounds has BioAssay Works completed?
BioAssay Works has completed 1 funding rounds.
How much funding did BioAssay Works raise in its most recent funding round?
BioAssay Works raised $150K in its most recent funding round.
Who are the lead investors in BioAssay Works's latest funding round?
The lead investor in BioAssay Works's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BioAssay Works's history?
The largest funding round in BioAssay Works's history was $150K.
See more information about BioAssay Works